Dr. Vanesa Gregorc

Dr. Vanesa Gregorc received her medical degree from the University of Perugia, where she completed postgraduate training specializing in Medical Oncology (summa cum laude honors). Today she is Director of Clinical Research and Innovation and Deputy Scientific Director of IRCCS Candiolo. It has been carrying out clinical, scientific and research activities in oncology for more than 25 years by promoting access to innovative therapies with the aim of providing patients with the most advanced therapeutic approaches.

A medical oncologist and researcher, Dr. Gregorc during her training in Italy, Switzerland and the U.S. acquired a solid foundation in clinical and translational research. In 2001, she moved to San Raffaele Hospital in Milan, Italy, where she coordinated the area of thoracic oncology, and in 2015, she took over as Director of the Thoracic, Melanoma and Head and Neck Oncology Unit of the Department of Medical Oncology. In 2020, she was appointed Director of the Strategic Oncology Diagnostic-Therapeutic Innovation Program and later Cancer Center Medical Area Coordinator and project leader for OECI Accreditation. She served as the Director of the Medical Area and Medical Oncology including the Day Hospital and Inpatient Unit of IRCCS Candiolo from 2021 to January 2025 and then covered the direction of clinical research and networking and internationalization activities of the Institute.

Throughout his career, he has also played a significant role in National and International institutional positions such as: Member of the Board of the European Organization of Oncology Institutes (OECI) for the recognition and confirmation of International Oncology Institutes, coordinator of the National Lung Cancer Research Program of the Lung Alliance Against Cancer (ACC) Working Group, and member of the Working Groups: Lung, Melanoma, Immunology and Genomics. She was also appointed by the Ministry of Health as a member of the committee for the definition of the first National Health Research Program, for the allocation of the budget for Current and Finalized Research, and for the recognition and confirmation of National Scientific Institutes (IRCCS), as well as a member of the committees for the appointment of Scientific Directors. She is involved in the Advisory Boards of national and international Oncology Institutes.

Author and co-author of more than 110 peer-reviewed articles, Dr. Gregorc is principal investigator of numerous Phase I, II and III sponsored and spontaneous clinical trials designed by her for patients with solid tumors predominantly lung cancer but also head and neck cancers, melanoma, breast and gynecologic cancers, in neoadjuvant, adjuvant and metastatic phases with novel biologic drug targets, immunotherapeutics and in support of precision medicine through extensive molecular profiling conducted routinely at the Institute. He collaborates with various patient associations and foundations in addition to conducting education activities in schools to promote primary prevention.